...
首页> 外文期刊>Journal of public health management and practice: JPHMP >Opioid-Prescribing Metrics in Washington State: Trends and Challenges
【24h】

Opioid-Prescribing Metrics in Washington State: Trends and Challenges

机译:华盛顿州的阿片式规定度量:趋势与挑战

获取原文
获取原文并翻译 | 示例
           

摘要

Context: Analyses of prescribing trends using prescription drug monitoring programs (PDMP) are impacted by changes in reporting requirements and in the scheduling of medications by the Drug Enforcement Administration. In 2014, the Drug Enforcement Administration changed the status of tramadol from an unscheduled to a scheduled medication. The addition of tramadol to the PDMP may affect the prevalence of opioid-prescribing metrics and the interpretation of prescribing trends. Objective: The objectives were to (1) examine trends in opioid prescribing in Washington State between 2012 and 2017, (2) assess the potential impact of adding tramadol to PDMP on these trends, and (3) describe challenges in defining and implementing opioid-prescribing metrics. Design: Analysis of quarterly summary statistics of opioid prescribing. Setting: Washington State. Participants: Washington State residents. Main Outcome Measures: The metrics include measures of opioid prescribing overall and by age group, chronic opioid prescribing, high-dose prescribing among those on chronic opioid therapy, prescribing of concurrent opioids and sedatives, days' supply of new opioid prescriptions, and transition from short-term to long-term use of opioids. Results: In Washington, the prevalence of any opioid prescribing, chronic opioid prescribing, high-dose opioid prescribing, and prescribing of concurrent opioids and sedatives declined between 2012 and 2017. The prevalence of opioid prescribing was higher in older than in younger age groups. The addition of tramadol to the Washington PDMP in 2014 affected the observed prevalence of all opioid metrics and of all opioid-prescribing trends. Conclusions about trends in opioid prescribing differ substantially depending on whether tramadol is included or not, particularly in 2014 and 2015. Conclusions: The development of opioid-prescribing metrics is relatively new. There is likely much benefit of standard definitions of opioid metrics at the state and national levels to track important trends and compare progress from state to state.
机译:背景信息:使用处方药监测计划(PDMP)的处方趋势分析受报告要求的变化和药物执法管理调度的影响。 2014年,药物执法管理局将曲马多的地位改为未经安排的预定药物治疗。添加曲马多的PDMP可能会影响阿片类药物规定度量的患病率和处方趋势的解释。目的:目标是(1)2012年至2017年期间华盛顿州在华盛顿州处方的趋势,(2)评估将曲马多加入这些趋势的潜在影响,(3)描述了定义和实施阿片的挑战 - 处方度量。设计:Opioid处方季度核算统计分析。设置:华盛顿州。参与者:华盛顿州居民。主要观察措施:指标包括整体和年龄组的阿片类药物,慢性阿片类药物,慢性阿片类药物治疗,同时表阿片类药物和镇静剂的规定,新阿片类药物处方的措施,以及转型短期到长期使用阿片类药物。结果:在华盛顿,2012年至2017年间,在华盛顿任何阿片类药物处方,慢性阿片类药物规定,高剂量阿片类药物和镇静剂的规定下降。阿片类药物规定的患病率高于年龄较小的年龄群体。 2014年对华盛顿PDMP的添加曲马多影响了所有阿片类药物和所有阿片类药物规定趋势的观察到患病率。关于阿片类药物规定趋势的结论显着取决于曲马多是否包括在2014年和2015年。结论:阿片类药物规范的发展相对较新。国家和国家层面的阿片类药物标准定义可能有很大的好处,以跟踪重要趋势,并将进展从国家与州进行比较。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号